PharmaSci SRL
PharmaSci reported total assets of €1.70m at the end of the 2025 financial year (annual accounts filed with the NBB on 21 Aug 2026).
The score of PharmaSci shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +56 % Total assets +2 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
PharmaSci's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 21 Aug 2026
- Year ended 31 Dec 2024filed on 29 Aug 2025
- Year ended 30 Sep 2023filed on 04 Apr 2024
- Year ended 30 Sep 2022filed on 06 Apr 2023
- Year ended 30 Sep 2021filed on 14 Feb 2022
PharmaSci's financial analysis
- Solvency49.6%sector median: 58.9%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of PharmaSci
PharmaSci's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0636.973.759
- VAT number
- BE0636973759
- Peppol
- Registered · 0208:0636973759 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 11 Sep 2015
- Registered office
- 3110 Rotselaar
- Latest accounts
- 2025 · filed on 21 Aug 2026
- Activity
- Business and other management consultancy activities (NACE 70200)
PharmaSci (SRL) has been based in Rotselaar since 2015, active in: business and other management consultancy activities. For 2025, it reports a net profit of 61,401 € and equity of 843,807 €; its revenue is not published. Its solvency stands at 49.6%, below the median of its sector (58.9%).
Companies similar to PharmaSci
Companies in the same business, of comparable size and area, outside its group.
- SEKA Consulting Business and other management consultancy activities Zaventem · balance sheet 742,541 €
- Marcers Business and other management consultancy activities Ixelles · balance sheet 580,249 €
- Valoir Business and other management consultancy activities Gesves · balance sheet 578,373 €
- ADSA Business and other management consultancy activities Ixelles · balance sheet 398,524 €
- IMES Business and other management consultancy activities Saint-Gilles · balance sheet 32,114 €
- I2SMD Business and other management consultancy activities Genk · balance sheet €2.05m
- Malaco Business and other management consultancy activities Kortrijk · balance sheet €1.70m
- NEBA Business and other management consultancy activities Maaseik · balance sheet €1.71m
Frequently asked questions about PharmaSci
What is the revenue of PharmaSci?
PharmaSci files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of PharmaSci?
In Belgium, the VAT number is the company number prefixed with BE: BE0636973759 for PharmaSci, if the company is VAT-registered. Its company number (CBE) is 0636.973.759.
Where is the registered office of PharmaSci?
According to the CBE register, the registered office of PharmaSci is in 3110 Rotselaar.
What is the equity of PharmaSci?
At the close of the 2025 financial year, the equity of PharmaSci amounts to 843,807 €, a solvency of 49.6% of total assets.
Who manages PharmaSci?
The register lists 1 active mandates at PharmaSci. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of PharmaSci
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →